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Summary A study of 953 invasive cutaneous malignant melanomas of the head and neck was performed to
determine differences between lentigo maligna melanoma and other histogenetic types with regard to patients
and sites affected; prognosis was analysed in 595 of these cases. The cases studied comprised all head and neck
melanomas registered with the Scottish Melanoma Group between 1979 and 1992, apart from the 3% of cases
that were unclassifiable or rare histogenetic types. The histogenetic types of melanoma were 498 (52%) lentigo
maligna melanoma (LMM), 237 (25%) superficial spreading melanoma (SSM) and 218 (23%) nodular
melanoma (NM). All types increased in incidence throughout the study period. Patients with LMM (mean age
73 years) and NM (mean 68 years) were significantly older than those with SSM (mean 57 years). There were
significant anatomical subsite differences related to sex of patients and histogenetic type of melanoma;
melanomas on the face were more frequent in females and 90% of LMM occurred at this site, whereas
melanomas on the scalp, neck and ears were more frequent in men. Kaplan-Meier estimates of the probability
of survival were produced for the 595 of these 953 patients with 5 year follow-up details. In this group of
patients the prognostic significance of tumour thickness, Clark level ofinvasion, ulceration, histogenetic type of
melanoma and number of mitoses were studied using stepwise variable selection of procedures. Each of these
possible prognostic factors attained individual significance but the tumour thickness was the dominant risk
factor in the proportional hazards analysis. When patients were divided into four sex/ulceration subgroups
(male/ulcerated, female/ulcerated, male/non-ulcerated, female/non-ulcerated) and analysed by proportional
hazards analysis, no variable other than the tumour thickness had any further prognostic effect. Histogenetic
type did not remain an independent prognostic variable at this stage. Despite sex and subsite differences, the
prognosis for invasive lentigo maligna melanoma does not differ from that for other histogenetic types after
controlling for tumour thickness.
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In Caucasians, about 10-20% of all malignant melanomas
occur on the head and neck (McGovern et al., 1980; Sober et
al., 1980; MacKie et al., 1985; Cox et al., 1987; Fisher, 1989;
O'Brien et al., 1991; Langford et al., 1993), and therefore
comprise a numerically important subset of a malignancy
that has shown increasing incidence over several decades in
most populations worldwide. Malignant melanoma of the
head and neck has some notable differences from those at
other body sites, especially a higher frequency of the lentigo
maligna type of melanoma (McGovern et al., 1980; Sober et
al., 1980; MacKie et al., 1985; Cox et al., 1987; Fisher, 1989;
Langford et al., 1993). From a management point ofview, an
important difference compared with other sites is that
excision margins of thicker malignant melanomas of the
head and neck may be limited by functional or cosmetic
considerations.
Although tumour thickness (Breslow, 1970) at these, as at
other sites, is accepted as a major prognostic factor, there is
some variation between studies regarding other prognostic
factors. One specific important question that remains is
whether the prognosis for lentigo maligna melanoma differs
significantly from the prognosis for melanoma of other
histogenetic types. Many of the larger studies have originated
from selected populations treated at tertiary referral centres
in countries with high levels of sun exposure (Conley and
Pack, 1963; Ballantyne, 1970; McGovern et al., 1980;
Gussack et al., 1983; Urist et al., 1984; Fisher, 1989; O'Brien
et al., 1991; Langford et al., 1993). We have therefore studied
the clinicopathological features of 953 malignant melanomas
of the head and neck registered with the Scottish Melanoma
Group (SMG) between 1979 and 1992 inclusive. These
comprise all cases of head and neck melanoma diagnosed
in Scotland over this 14 year period and are therefore a
valuable database for population-based epidemiology. To
clarify prognostic issues discussed in an earlier study (Cox et
al., 1987), we have analysed prognostic factors in the 595
cases in this database for whom follow-up data was available
until at least the fifth year after diagnosis (all cases 1979-86).
Methods
Details of 953 patients with clinical stage I invasive malignant
melanoma of the head and neck were available. These
comprised the 97% of cases of invasive malignant melanoma
of the three main histogenetic types at this body site that had
been registered with the Scottish Melanoma Group from
1979 to 1992 (the other 3% were melanomas of unclassifiable
histogenetic type); patients with non-invasive lentigo maligna
or intraepidermal (Clark level I) in situ malignant melanoma
were excluded. Registration methods have been described in
detail elsewhere (MacKie et al., 1985). The registrations, to
the best of our knowledge, comprise all malignant
melanomas occurring in the population (5 million persons)
in Scotland, and are updated by contacting the responsible
clinician periodically for details of outcome.
The factors that were considered comprised age and sex of
patients, histogenetic type of melanoma, and anatomical
subsite affected (face, scalp, neck, ears). Differences between
subgroups involving these variables were analysed using
Wilcoxon -Mann -Whitney, or x2 tests as appropriate, and
allowing for multiple comparisons by means of a Bonferroni-
based procedure. Survival proffles were based on deaths due
to melanoma; deaths due to unrelated causes were treated as
censored data.
For the 595 patients diagnosed from 1979 to 1986, in
whom follow-up details were complete to the fifth year after
Correspondence: NH Cox
Received 7 March 1995; revised 12 October 1995; accepted 27
October 1995Head and neck melanoma
NH Cox et a! e
941
diagnosis, additional factors were analysed by univariate
analysis for their prognostic significance. These were tumour
thickness, Clark level of invasion, presence of ulceration and
number of mitoses (low, medium, high). Other more detailed
analyses were performed as described below; the numbers of
cases entered into each of these is documented in the details
of each analysis and was determined by the number with
complete data for all relevant parts of the analysis in
question. In 516 of these 595 patients (87%) there was
complete information on all of the prognostic factors
considered (Table III), as well as on the outcome in terms
of deaths due to melanoma.
Kaplan-Meier estimates of the probability of survival
were used to describe the survival profiles, and the effects of
the potential prognostic risk factors were studied using log-
rank tests and proportional hazards modelling, which
involved forward stepwise and backward elimination vari-
able selection procedures (Everitt, 1989). A previous study
analysing the full SMG database for prognosis of melanoma
at all body sites had demonstrated that the most important
combinations of risk factors involved tumour thickness,
ulceration and sex of patients (MacKie et al., 1995). A
separate stepwise proportional hazards analysis was therefore
performed for each of the four sex/ulceration subgroups
(male ulcerated, male non-ulcerated, female ulcerated, female
non-ulcerated); the prognostic factors entered for this
analysis were complete in 546 patients for whom a minimum
of 5 year follow-up was available.
Results
Incidence by histogenetic type
All histogenetic types of malignant melanoma of the head
and neck increased in incidence over the period studied
(Figure 1). Malignant melanoma at this site accounted for
21% of the total number of registrations for all body sites;
lentigo maligna melanoma (LMM) on the head and neck
accounted for 83% of all cases of LMM. The proportions of
the different histogenetic types (see Table I for absolute
values) were: LMM 52%, superficial spreading melanoma
(SSM) 25%, nodular melanoma (NM) 23%.
Age and sex related to histogenetic type
There were significant differences among histogenetic types
relating to the age of patients (Table I). Patients with LMM
or with NM were significantly older than those with SSM
(both P<0.0001, Wilcoxon-Mann-Whitney test); those
with LMM were older than those with NM but this was
not statistically significant. The ratio of females to males for
each histogenetic type was LMM 1.74:1, SSM 1.24:1, NM
0.98:1 (Table I). For each of these histogenetic types, the
mean age for female patients was 2-3 years greater than that
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Figure 1 Registrations of melanoma of the head and neck in
Scotland 1979-92. ( ), Total; (......), LMM; (- -), SSM;
(
- - - ), NM.
Anatomical subsite
The anatomical subsite distribution of malignant melanoma
on the head and neck is shown in Table II, related to sex of
patients and to histogenetic type of melanoma. All
histogenetic types were most frequent on the face but there
were significant differences in the number of each type at this
site (which accounted for 90% of LMM but only 70% of
NM and 56% of SSM, (P<0.00001, x2 test). There were also
significant differences in the distribution of histogenetic types
on the neck (P<0.0001, X2 test) and ears (P<0.05, X2 test).
There were only four cases ofmalignant melanoma of the lip,
which are not included in the Table.
There were significant differences between the sexes in the
proportions of melanoma on the face (P<0.0001, x2 test),
scalp (P<0.001, x2 test) and ears (P<0.001, X2 test).
Specifically, females have the great majority of melanomas
on the face whereas males have a significantly higher
proportion on the neck and ears.
Prognosis
A Kaplan-Meier estimate of the survival profile produced
for all patients demonstrated a steady slow decrease in
survival over a 10 year period, the 5 year and 10 year survival
figures being 85% and 75% respectively. The same analysis
for each histogenetic type separately demonstrated better
survival for the LMM histogenetic subtype when compared
with the other subtypes in isolation, but 63% of these were
less than 1.5 mm thick and therefore expected to have a good
prognosis. As will be seen below, histogenetic type did not
remain an independent prognostic factor when a stepwise
proportional hazards model was used.
The individual significance of each of the possible
prognostic risk factors was statistically assessed (Table III),
demonstrating that prognosis was significantly related to each
of the following in isolation: sex of patients, histogenetic type
ofmelanoma, presence ofulceration, tumour thickness, Clark
level of invasion and level of mitotic activity. A stepwise
proportional hazards analysis was performed, which demon-
strated (Table III) that tumour thickness was clearly the
dominant risk factor. Male sex, ulceration and deep invasion
(level 5) all had a significant adverse effect after controlling
for thickness and for each other. LMM had a better
prognosis when compared with NM and SSM, but this was
eliminated after controlling for thickness and the other
significant variables.
Since the two categorical factors, sex and presence/absence
of ulceration, were the two most important risk factors after
correcting for tumour thickness, and since a similar approach
proved effective in analysis of the whole of the SMG
database (MacKie et al., 1995), a separate stepwise
proportional hazards analysis was performed for each of
the four sex-ulceration subgroups (i.e. females with ulcerated
lesions, females with non-ulcerated lesions, males with
ulcerated lesions, and males with non-ulcerated lesions).
Once divided into these groups, only the tumour thickness
had any further prognostic effect, i.e. the interactions between
sex, ulceration and tumour thickness eliminated the effect of
Table I Numbers of head and neck malignant melanoma studied,
demonstrating age and sex differences between histogenetic types.
Histogenetic Number (%) Age (years)
type Females Males Total Mean Median Range
LMM 316 182 498 73 74 27-97a
(57%) (46%) (52%)
SSM 131 106 237 57 60 15-99
(24%) (27%) (25%)
NM 108 110 218 68 73 15-100"
(19%) (28%) (23%)
Total 555 398 953
a LMM average age significantly older than SSM,P<0.0001. bNM
average age significantly older than SSM, P<0.0001.
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Table II Distribution of malignant melanoma by anatomical site, related to sex of patients and histogenetic type of melanomaa
Sex ofpatients Histogenetic type ofmelanoma
Site Female Male LMM SSM NM
Face 473 255 445 131 152
(86%) (64%) (90%) (56%) (70%)
Scalp 10 34 16 14 14
(2%) (9%) (3%) (6%) (6%)
Neck 52 67 18 69 32
(9%) (17%) (4%) (29%) (15%)
Ears 16 42 18 22 18
(3%) (11%) (4%) (9%) (8%)
a Four patients with lip lesions not included.
Table m Results of survival analyses on factors affecting melanoma prognosis
Individual significance onfull survival data Order of inclusion in stepwise proportional hazards analysis
Factor x2 (d.f.) P-value Order x2 (d.f.) P-valuefor inclusion
Tumour thickness 83 (1) <0.0001 1 83 (1) <0.0001
Level of invasion 50 (3) <0.0001 4 6 (I)a 0.02
(2,3,4,5)
Ulceration 46 (1) <0.0001 3 6 (1) 0.02
(yes, no)
Level of mitosis 18 (2) <0.001 Not includedb
(low, medium, high)
Histogenetic type 20 (1) <0.001 Not includedb
(LMM, non-LMM)
Sex 10 (1) <0.005 2 9 (1) <0.005
(female, male)
Site 5 (3) 0.17 Not includedb
(face, scalp, neck, ears)
Age 0.45 (1) 0.50 Not includedb
a Prognosis forlevel ofinvasion 5 is significantly worse than allother levelswhichshow no significantdifferences inprognosiswith respect to each
other. b This factor did not achieve siginficance (i.e. P-value>0.05) when tested in a proportional hazards model including the four significant
factors (i.e. tumour thickness, sex, ulceration and level ofinvasion).
level of invasion demonstrated in the simpler stepwise
analysis. The survival profiles for the four sex/ulceration
subgroups clearly demonstrated that increasing tumour
thickness reduced survival prospects in all four groups, the
worst prognosis being in men with thick ulcerated
melanomas.
Discussion
This study is one of the largest analyses of invasive head and
neck melanoma reported, and is the most complete study
based on a geographically defined population rather than an
institutional series. It is also notable in covering patients
living in a temperate climate; with few exceptions (Ringborg
et al., 1993; Andersson et al., 1993) other studies with a
similar number of cases have been in areas of the world with
much greater sunlight exposure. This may explain some of
the differences in histogenetic types and anatomical sites of
melanoma between the present study and other reported
series.
Despite having excluded lentigo maligna/LMM in situ,
which mainly occur on the face, and all other in situ
melanomas, the proportion of malignant melanomas arising
on the head and neck in the present study (21% of the total
Scottish Melanoma Group database) is higher than the 11 -
17% reported in other large studies (Sober et al., 1980;
Gussack et al., 1983; Fisher, 1989; O'Brien et al., 1991;
Langford et al., 1993). Most striking is the high proportion of
patients with LMM (52%), which is considerably greater
than the 24% reported in a recent large European study
(Ringborg et al., 1993), and 15-16% in large Australian and
American studies (Fisher, 1989; O'Brien et al., 1991;
Langford et al., 1993). These head and neck LMM
accounted for 83% of all LMM registered with the SMG, a
similar proportion to that reported by many authors (Conley
and Pack, 1963; Sober et al., 1980; Blois et al., 1983),
although the reported proportion varies from 36% (Van der
Esch, cited by McGovern et al., 1980) to 92% (McGovern et
al., 1980). The older age ofpatients with LMM in the present
and other studies (McGovern et al., 1980; Holman and
Armstrong, 1984; Langford et al., 1993; Ringborg et al.,
1993), is consistent with the theory that LMM is related more
to cumulative lifetime sunlight exposure than the other
varieties, which are postulated to be related to acute
intermittent sunlight exposure (MacKie, 1981; Holman et
al., 1983; Swerdlow, 1984; Elwood et al., 1987). Depending
on occupation and leisure interests, the head and neck may
be exposed to sunlight in either of these patterns. However,
the steady increase in all three main histogenetic subtypes of
melanoma during the study period is not in support of
different aetiologies (the sharp increase in SMM in 1985,
shown in Figure 1, is probably due to a Scottish melanoma
educational campaign as registrations increased at all body
sites in this year). Furthermore, personal factors identified as
risk factors for lentigo maligna and lentigo maligna
melanoma in a recent study (McHenry et al., 1995) are also
recognised as risk factors for SSM and NM.
The results of the present study confirm our earlier report
(Cox et al., 1987) of significant anatomical subsite differences
between the sexes and for histogenetic types of melanoma.
The overall distribution of melanoma at different subsites
(face, scalp, ear and neck) is similar to other large series
(Fisher, 1989; O'Brien et al., 1991; Ringborg et al., 1993), and
the male predominance of melanoma on the neck, scalp and
ears also confirms results of other authors (Fitzpatrick et al.,
1972; Knutson et al., 1972; Byers et al., 1980; Day et al.,
1982a; Gussack et al., 1983; Fisher, 1989; O'Brien et al.,
1991; Ringborg et al., 1993). The reasons for this are
uncertain but baldness and shorter hair styles in men are
likely to be the explanation. Most studies of head and neck
melanoma have reported a male predominance (Kragh andHead and neck melanoma
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Erich, 1960; Conley and Pack, 1963; Catlin, 1966; Ballantyne,
1970; Fitzpatrick et al., 1972; Knutson et al., 1972; Donellan
et al., 1972; Simons, 1972; Ames et al., 1976; Gussack et al.,
1983; Urist et al., 1984; Fisher, 1989; O'Brien et al., 1991),
although a few studies (McGovern et al., 1980; Wanebo et
al., 1988; Ringborg et al., 1993; Andersson et al., 1993)
support our finding an excess of females. Where data for
other body sites is available from the same study population,
the male-female ratio is higher for the head and neck than
for other body sites (Hansen and McCarten, 1974; Ames et
al., 1976; Gussack et al., 1983; Cox et al., 1987; Langford et
al., 1993) and an absolute or relative excess of females with
LMM is generally reported in studies where this has been
analysed (McGovern et al., 1980; Cox et al., 1987; Ringborg
et al., 1993).
It is interesting to consider reasons for the differences
between the Swedish Melanoma Group study (Ringborg et
al., 1993) and the present report from a similar latitude.
LMM was less frequent in that study (24% compared with
our 52%), although the anatomical subsite and sex
differences were similar to our results. In particular, LMM
in the Swedish study was overrepresented in females
(female-male ratio 2.4:1 compared with 1.1:1 for all sites
in their study population), and the LMM prognosis was
better. However, it is not stated whether the Swedish data
include non-invasive LMM, which would clearly improve the
prognosis for the LMM group, and unfortunately the authors
felt that LMM was a separate entity and excluded it from the
detailed analysis of survival.
Potential prognostic factors for melanoma that were
analysed in the present study were those identified in large
studies of melanoma at any site. Because there are many
prognostic variables, which may all have individual
significance, but which may be interrelated (e.g. thickness
and depth of invasion), the stepwise analysis was used to
identify the most important prognostic indicators. This
demonstrated that male sex and presence of ulceration
significantly worsened survival but confirmed the tumour
thickness to be the most important factor, as determined in
virtually all studies ofmelanoma. The survival profiles for the
four sex/ulceration subgroups clearly demonstrated that
increasing tumour thickness reduced survival prospects in
all four groups. Ulceration is a significant predictive factor in
many studies that have controlled for tumour thickness
(Balch et al., 1978, 1980; Van der Esch, 1981; Day et al.,
1982b; Urist et al., 1984; Shaw et al., 1985; O'Brien et al.,
1991; Andersson et al., 1993; Langford et al., 1993; MacKie
et al., 1995) and even retains significance in patients with
lymph node metastasis (Balch et al., 1980). Male sex has been
associated with poorer prognosis in most studies of head and
neck melanoma (Ballantyne, 1970; Fitzpatrick et al., 1972;
Hansen and McCarten, 1974; Gussack et al., 1983; Cox et al.,
1987; O'Brien et al., 1991; Langford et al., 1993; Ringborg et
al., 1993; Andersson et al., 1993), although some studies
report no sex difference (Catlin, 1966; Knutson et al., 1972;
McGovern et al., 1980) and one reported a better prognosis
in men (Southwick et al., 1963).
Several authors have identified melanoma of the head and
neck as having a worse prognosis than other body sites (Day
et al., 1982b; Blois et al., 1983; Gussack et al., 1983; Urist et
al., 1984; Fisher, 1989; Hersey et al., 1991), and some have
identified subsite differences in prognosis for head and neck
melanomas on univariate (Ballantyne, 1970) or multivariate
(Urist et al., 1984; Wanebo et al., 1988; Fisher, 1989; O'Brien
et al., 1991; Ringborg et al., 1993) analysis. In general, a
worse prognosis has been reported for scalp (Urist et al.,
1984; Wanebo et al., 1988; Fisher, 1989; O'Brien et al., 1991;
Ringborg et al., 1993) or scalp and ear (Wanebo et al., 1988).
Despite the differences in sex of patients and histogenetic
types ofmelanoma at different anatomical subsites, the site of
melanoma did not have independent significance in the
proportional hazards analysis in the present study.
LMM has been reported to have a better prognosis than
other histogenetic types of melanoma, but this data is
confounded both by inclusion of lentigo maligna (McGo-
vern et al., 1980) and by failure to control for tumour
thickness in older studies. Some studies using multivariate
analyses do still report a better prognosis for this histogenetic
type of melanoma (Urist et al., 1984; Wanebo et al., 1988;
O'Brien et al., 1991). However, other authors are in
agreement with our conclusion that, thickness for thickness,
LMM does not have a better prognosis than other types of
melanoma once invasion has occurred and when sex and
ulceration are taken into account (Gussack et al., 1983; Koh
et al., 1984; Pittelkow et al., 1986; Langford et al., 1993). The
report by Urist et al. (1984), which indicated that ulceration
was a more important variable than thickness for LMM, is
not supported by the present or most other studies, although
ulceration is undoubtedly an important prognostic feature
after accounting for tumour thickness. Our results clearly
demonstrate that the most important prognostic variable for
all histogenetic types of head and neck melanoma is the
tumour thickness.
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